Pharma News

The latest developments from pharmaceutical and biopharmaceutical companies, both innovator and generic-drug companies, and leading regulatory news.

Vertex Pharmaceuticals has agreed to acquire Semma Therapeutics, a privately held biotechnology company specializing in Type 1 diabetes treatments, for $950 million in cash. Semma has developed a therapeutic approach to address the causal human...

Boehringer Ingelheim (BI) reports that Allan Hillgrove, member of the company’s Board of Managing Directors responsible for the Human Pharma and the Biopharma business, will retire at the end of this year and will be succeeded by Dr. Carine...